サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1425220

アミノグリコシドの世界市場レポート 2024年

Aminoglycosides Global Market Report 2024
出版日: 受注後更新 | 発行: The Business Research Company | ページ情報: 英文 200 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
アミノグリコシドの世界市場レポート 2024年
出版日: 受注後更新
発行: The Business Research Company
ページ情報: 英文 200 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 目次
概要

アミノグリコシドの市場規模は、近年力強く成長しています。2023年の17億7,000万米ドルから、2024年には18億6,000万米ドルへ、CAGR5.1％で成長すると予測されています。過去実績期間中に見られた拡大は、抗生物質の発見と開発、医薬品化学の発展、グラム陰性感染症の治療におけるこれらの抗生物質の臨床的有効性、広域抗菌活性、院内感染対策への取り組み、世界の人口増加、手術後感染症の予防、研究開発への多額の投資といった主な要因によるものです。

アミノグリコシド市場では、プロセス革新が重要な動向として浮上しています。この分野の主要企業は、市場での地位を強化するため、斬新なプロセス・ソリューションの開発に注力しています。その一例として、CPC Biotechは2021年9月、アミノグリコシド系抗生物質の不活性化用に設計された酵素ベースの製品Aminosniperを発表しました。アミノスナイパーは、アミノグリコシドクラスの抗生物質で汚染された製品や表面の無菌性を確認するための実験用試薬として機能します。この戦略的イノベーションは、プロセス・ソリューションの進歩に対する業界のコミットメントを反映しており、市場の成長と技術的進歩に貢献しています。

2023年のアミノグリコシド市場で最大の地域はアジア太平洋です。北米は予測期間中に最も急成長する地域と予想されます。アミノグリコシド市場レポートの対象地域は、アジア太平洋、西欧、東欧、北米、南米、中東・アフリカです。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

  • 高インフレが市場に与える影響
  • ウクライナ・ロシア戦争が市場に与える影響
  • COVID-19による市場への影響

第5章 世界市場規模と成長

  • 世界のアミノグリコシド市場の促進要因と抑制要因
    • 市場の促進要因
    • 市場の抑制要因
  • 世界のアミノグリコシド市場規模実績と成長、2018年～2023年
  • 世界のアミノグリコシド市場規模と成長予測、2023年～2028年、2033年

第6章 市場セグメンテーション

  • 世界のアミノグリコシド市場、製品別セグメンテーション、実績と予測、2018年～2023年、2023年～2028年、2033年
  • ネオマイシン
  • トブラマイシン
  • ゲンタマイシン
  • アミカシン
  • パロモマイシン
  • ストレプトマイシン
  • カナマイシン
  • その他の製品
  • 世界のアミノグリコシド市場、投与経路別セグメンテーション、実績と予測、2018年～2023年、2023年～2028年、2033年
  • 注射剤（非経口）
  • 餌
  • 乳房内
  • 話題
  • 局所
  • 世界のアミノグリコシド市場、用途別セグメンテーション、実績と予測、2018年～2023年、2023年～2028年、2033年
  • 獣医
  • 皮膚感染症
  • 呼吸器疾患
  • 尿路感染症と骨盤疾患
  • その他の病気

第7章 地域と国の分析

  • 世界のアミノグリコシド市場、地域別、実績と予測、2018年～2023年、2023年～2028年、2033年
  • 世界のアミノグリコシド市場、国別、実績と予測、2018年～2023年、2023年～2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • アミノグリコシド市場の競合情勢
  • アミノグリコシド市場企業プロファイル
    • Kremoint Pharma Pvt. Ltd.
    • Vega Pharma Ltd.
    • Jiangxi Bolai Pharmacy Co. Ltd.
    • Xian Wison Biological Technology Co. Ltd.
    • Hangzhou Uniwise International Co. Ltd.

第31章 競合ベンチマーキング

第32章 競合ダッシュボード

第33章 主要な合併と買収

第34章 将来の見通しと可能性の分析

第35章 付録

目次
Product Code: r12451

Aminoglycosides Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on aminoglycosides market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for aminoglycosides? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The aminoglycosides market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

  • 1) By Product: Neomycin; Tobramycin; Gentamicin; Amikacin; Paromomycin; Streptomycin; Kanamycin; Other Products
  • 2) By Route Of Administration: Injectables (Parenteral); Feed; Intra-Mammary; Topical; Oral
  • 3) By Application: Veterinary; Skin Infection; Respiratory Diseases; UTI And Pelvic Diseases; Other Diseases
  • Companies Mentioned: Kremoint Pharma Pvt. Ltd.; Vega Pharma Ltd.; Jiangxi Bolai Pharmacy Co. Ltd.; Xian Wison Biological Technology Co. Ltd.; Hangzhou Uniwise International Co. Ltd.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Aminoglycosides, a class of antibiotics renowned for their ability to impede protein synthesis, play a crucial role in treating infections caused by aerobic gram-negative bacilli. These infections commonly manifest in the abdomen and urinary tract, as well as in cases of bacteremia and endocarditis.

Among the primary products in the aminoglycoside category are neomycin, tobramycin, gentamicin, amikacin, paromomycin, streptomycin, kanamycin, and others. Neomycin, for instance, is specifically employed to prevent bacterial infections in the intestines. Derived from the metabolic products of Streptomyces fradiae, neomycin is recognized as a broad-spectrum aminoglycoside antibiotic. Aminoglycosides are administered through various routes, including injectables (parenteral), feed, intra-mammary, topical, and oral applications. Their use extends across veterinary medicine, addressing conditions such as skin infections, respiratory diseases, urinary tract infections, pelvic diseases, and various other ailments.

The aminoglycosides market research report is one of a series of new reports from The Business Research Company that provides aminoglycosides market statistics, including aminoglycosides industry global market size, regional shares, competitors with an aminoglycosides market share, detailed aminoglycosides market segments, market trends and opportunities, and any further data you may need to thrive in the aminoglycosides industry. This aminoglycosides market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The aminoglycosides market size has grown strongly in recent years. It will grow from $1.77 billion in 2023 to $1.86 billion in 2024 at a compound annual growth rate (CAGR) of 5.1%. The expansion observed during the historical period can be attributed to key factors such as the discovery and development of antibiotics, advancements in medicinal chemistry, the clinical effectiveness of these antibiotics in treating gram-negative infections, their broad-spectrum antibacterial activity, initiatives for hospital-acquired infection control, global population growth, prevention of post-surgery infections, and significant investments in research and development.

The aminoglycosides market size is expected to see strong growth in the next few years. It will grow to $2.32 billion in 2028 at a compound annual growth rate (CAGR) of 5.6%. The anticipated growth in the forecast period can be attributed to several factors, including advancements in antibiotic stewardship practices, the implementation of personalized medicine approaches, innovations in drug delivery methods, the global spread of antibiotic-resistant strains, a heightened focus on addressing rare diseases, expanding applications in dermatology, and increased efforts in patient education regarding antibiotic use. Major trends expected during the forecast period encompass biotechnological innovations, the rise of combination therapies, technological advancements in production processes, and intensified price competition within the market.

The aminoglycosides market is anticipated to witness growth due to the escalating incidences of animal disease outbreaks. These outbreaks significantly impact the normal functions of animals and create a demand for aminoglycosides, like amikacin and gentamicin, widely used in veterinary medicine. A recent example is the anthrax outbreak reported and monitored in remote areas of Canada's Wood Buffalo National Park in July 2022. This trend is expected to continue, further boosting the demand for aminoglycosides within the market.

The growing ownership of pets is poised to fuel the expansion of the aminoglycosides market. The increased number of pet owners, who are responsible for the care and well-being of animals kept as companions, contributes to the market's growth by expanding the customer base. This surge in pet ownership encourages preventive healthcare practices for pets and drives investments in veterinary pharmaceuticals, including aminoglycosides, to address various health needs. An example of this growth is evident in the UK, where approximately 57% of households, totaling 16.2 million, have 38 million pets, as reported by Improve International in March 2023. This rise in pet ownership remains a driving force behind the growth of the aminoglycosides market.

Process innovation emerges as a significant trend in the aminoglycosides market. Key companies within this sector are focused on developing novel process solutions to fortify their market positions. As an illustration, in September 2021, CPC Biotech introduced Aminosniper, an enzyme-based product designed for the inactivation of aminoglycosidic antibiotics. Aminosniper serves as a lab reagent for verifying the sterility of products or surfaces contaminated by antibiotics from the aminoglycosides class. This strategic innovation reflects the industry's commitment to advancing process solutions, contributing to the market's growth and technological advancements.

Major companies within the aminoglycosides market are introducing innovative products like the Aminosniper inactivator to enhance their market competitiveness and profitability. This inactivator, a broad-spectrum solution designed to neutralize aminoglycoside antibiotics, serves as an essential tool in rendering antibiotics such as ribostamycin, gentamicin, tobramycin, and neomycin inactive. In September 2021, Cpc Biotech S.R.L., an Italy-based biotechnology company, unveiled the Freeze-dried Aminosniper, available in a freeze-dried format. This product finds applications in various areas, including media fill, total count, aminoglycoside sterility testing, and assessing the susceptibility of novel aminoglycoside antibiotics to inactivation by aminoglycosidases.

In April 2022, Animal Dermatology Group Inc., a US-based veterinary company, executed the acquisition of Austin Veterinary Dermatology & Allergy. The strategic acquisition, completed for an undisclosed amount, is part of Animal Dermatology Group's ongoing efforts to expand its geographic presence and consolidate its market position. Through this acquisition, the company aims to broaden its scope and offer top-tier treatment for skin diseases across more regions. This move reinforces Animal Dermatology Group's commitment to enhancing its expertise in veterinary dermatology. Austin Veterinary Dermatology & Allergy, a US-based biotechnology company, aligns well with the expansion goals of Animal Dermatology Group.

Major companies operating in the aminoglycosides market report are Kremoint Pharma Pvt. Ltd., Vega Pharma Ltd., Jiangxi Bolai Pharmacy Co. Ltd., Xian Wison Biological Technology Co. Ltd., Hangzhou Uniwise International Co. Ltd., HuvePharma Inc., Yi Chang Veterinary Medicine Factory, Medson Pharmaceuticals, Medico Remedies Pvt. Ltd., Cipla Limited, Pfizer Inc., Allergan PLC, Teva Pharmaceutical Industries Ltd., Zoetis Inc., Taiwan Fructose Sdn. Bhd., Novartis AG, Johnson & Johnson Inc., Bristol Myers Squibb Company, Sandoz International GmbH, Sun Pharmaceutical Industries Ltd., Zydus Lifescience limited, Lupin Limited, Aurobindo Pharma Limited, Fresenius Kabi AG, Aspen Pharmacare Holdings Limited, Mylan N.V., Sanofi SA, Wyeth Pharmaceuticals Inc., Zhejiang Hisun Pharmaceutical Co. Ltd., GlaxoSmithKline plc

Asia-Pacific was the largest region in the aminoglycosides market in 2023. North America is expected to be the fastest-growing region in the forecast period. The regions covered in the aminoglycosides market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the aminoglycosides market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The aminoglycosides market consists of sales of plazomicin and netilmicin. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Table of Contents

1. Executive Summary

2. Aminoglycosides Market Characteristics

3. Aminoglycosides Market Trends And Strategies

4. Aminoglycosides Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Aminoglycosides Market Size and Growth

  • 5.1. Global Aminoglycosides Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Aminoglycosides Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Aminoglycosides Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Aminoglycosides Market Segmentation

  • 6.1. Global Aminoglycosides Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Neomycin
  • Tobramycin
  • Gentamicin
  • Amikacin
  • Paromomycin
  • Streptomycin
  • Kanamycin
  • Other Products
  • 6.2. Global Aminoglycosides Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Injectables (Parenteral)
  • Feed
  • Intra-Mammary
  • Topical
  • Oral
  • 6.3. Global Aminoglycosides Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Veterinary
  • Skin Infection
  • Respiratory Diseases
  • UTI And Pelvic Diseases
  • Other Diseases

7. Aminoglycosides Market Regional And Country Analysis

  • 7.1. Global Aminoglycosides Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Aminoglycosides Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Aminoglycosides Market

  • 8.1. Asia-Pacific Aminoglycosides Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Aminoglycosides Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Aminoglycosides Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Aminoglycosides Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Aminoglycosides Market

  • 9.1. China Aminoglycosides Market Overview
  • 9.2. China Aminoglycosides Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Aminoglycosides Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Aminoglycosides Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Aminoglycosides Market

  • 10.1. India Aminoglycosides Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Aminoglycosides Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Aminoglycosides Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Aminoglycosides Market

  • 11.1. Japan Aminoglycosides Market Overview
  • 11.2. Japan Aminoglycosides Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Aminoglycosides Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Aminoglycosides Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Aminoglycosides Market

  • 12.1. Australia Aminoglycosides Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Aminoglycosides Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Aminoglycosides Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Aminoglycosides Market

  • 13.1. Indonesia Aminoglycosides Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Aminoglycosides Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Aminoglycosides Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Aminoglycosides Market

  • 14.1. South Korea Aminoglycosides Market Overview
  • 14.2. South Korea Aminoglycosides Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Aminoglycosides Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Aminoglycosides Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Aminoglycosides Market

  • 15.1. Western Europe Aminoglycosides Market Overview
  • 15.2. Western Europe Aminoglycosides Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Aminoglycosides Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Aminoglycosides Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Aminoglycosides Market

  • 16.1. UK Aminoglycosides Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Aminoglycosides Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Aminoglycosides Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Aminoglycosides Market

  • 17.1. Germany Aminoglycosides Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Aminoglycosides Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Aminoglycosides Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Aminoglycosides Market

  • 18.1. France Aminoglycosides Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Aminoglycosides Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Aminoglycosides Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Aminoglycosides Market

  • 19.1. Italy Aminoglycosides Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Aminoglycosides Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Aminoglycosides Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Aminoglycosides Market

  • 20.1. Spain Aminoglycosides Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Aminoglycosides Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Aminoglycosides Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Aminoglycosides Market

  • 21.1. Eastern Europe Aminoglycosides Market Overview
  • 21.2. Eastern Europe Aminoglycosides Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Aminoglycosides Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Aminoglycosides Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Aminoglycosides Market

  • 22.1. Russia Aminoglycosides Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Aminoglycosides Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Aminoglycosides Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Aminoglycosides Market

  • 23.1. North America Aminoglycosides Market Overview
  • 23.2. North America Aminoglycosides Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Aminoglycosides Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Aminoglycosides Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Aminoglycosides Market

  • 24.1. USA Aminoglycosides Market Overview
  • 24.2. USA Aminoglycosides Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Aminoglycosides Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Aminoglycosides Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Aminoglycosides Market

  • 25.1. Canada Aminoglycosides Market Overview
  • 25.2. Canada Aminoglycosides Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Aminoglycosides Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Aminoglycosides Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Aminoglycosides Market

  • 26.1. South America Aminoglycosides Market Overview
  • 26.2. South America Aminoglycosides Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Aminoglycosides Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Aminoglycosides Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Aminoglycosides Market

  • 27.1. Brazil Aminoglycosides Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Aminoglycosides Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Aminoglycosides Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Aminoglycosides Market

  • 28.1. Middle East Aminoglycosides Market Overview
  • 28.2. Middle East Aminoglycosides Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Aminoglycosides Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Aminoglycosides Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Aminoglycosides Market

  • 29.1. Africa Aminoglycosides Market Overview
  • 29.2. Africa Aminoglycosides Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Aminoglycosides Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Aminoglycosides Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Aminoglycosides Market Competitive Landscape And Company Profiles

  • 30.1. Aminoglycosides Market Competitive Landscape
  • 30.2. Aminoglycosides Market Company Profiles
    • 30.2.1. Kremoint Pharma Pvt. Ltd.
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Vega Pharma Ltd.
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Jiangxi Bolai Pharmacy Co. Ltd.
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Xian Wison Biological Technology Co. Ltd.
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Hangzhou Uniwise International Co. Ltd.
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Global Aminoglycosides Market Competitive Benchmarking

32. Global Aminoglycosides Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Aminoglycosides Market

34. Aminoglycosides Market Future Outlook and Potential Analysis

  • 34.1 Aminoglycosides Market In 2028 - Countries Offering Most New Opportunities
  • 34.2 Aminoglycosides Market In 2028 - Segments Offering Most New Opportunities
  • 34.3 Aminoglycosides Market In 2028 - Growth Strategies
    • 34.3.1 Market Trend Based Strategies
    • 34.3.2 Competitor Strategies

35. Appendix

  • 35.1. Abbreviations
  • 35.2. Currencies
  • 35.3. Historic And Forecast Inflation Rates
  • 35.4. Research Inquiries
  • 35.5. The Business Research Company
  • 35.6. Copyright And Disclaimer